Vipera latastei
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA838693 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Vipera kaznakovi venom gland raw sequence reads
| PRJNA505487 | ENA
Project description:Vipera anatolica senliki Venom Gland Transcriptome and Assembly
| PRJNA560445 | ENA
Project description:Vipera aspis venom gland transcriptome: raw sequence reads and VTBuilder assembly
| PRJNA594707 | ENA
Project description:Vipera berus berus (European viper)
| PRJNA170536 | ENA
Project description:Vipera latastei (snub-nosed viber) genome, rVipLat1, alternate haplotype
| PRJNA838199 | ENA
Project description:Vipera latastei (snub-nosed viber) genome, rVipLat1, primary haplotype
| PRJNA838200 | ENA
Project description:Venomics of the Vipera a. transcaucasiana and Vipera a. montandoni by bottom-up and intact mass profiling
2017-08-31 | MSV000081493 | MassIVE
Project description:The nose-horned viper, its nominotypical subspecies Vipera ammodytes ammodytes (Vaa) in particular is, medically, the most relevant snake in Europe. The local and systemic clinical manifestations of poisoning by the venom of this snake are the result of the pathophysiological effects inflicted by enzymatic and non-enzymatic venom components acting, most prominently, on blood, cardiovascular and nerve systems. This venom comprises the most complex mixture of pharmacologically active proteins and peptides of all European snakes. To help improve the current antivenom therapy towards higher specificity and efficiency, and to assist drug discovery, we have constructed, by combining transcriptomic and proteomic analyses, the most comprehensive library yet of the Vaa venom proteins and peptides. At the protein level, 57 venom proteins belonging to 16 different protein families have been identified and, with SVSPs, sPLA2s, snaclecs and SVMPs, comprise about 80% of all venom proteins.
2019-05-06 | PXD012752 | Pride
Project description:Snake venom is a rich source of peptides and proteins with a wide range of actions. Many of the components of the venom are currently being tested for their usefulness in the treatment of many diseases ranging from neurological and cardiovascular to cancer. It is also important to constantly search for new proteins and peptides with properties not yet described. The venom of Vipera berus berus has hemolytic, proteolytic and cytotoxic properties, but its exact composition and the factors responsible for these properties are not known. Therefore, an attempt was made to identify proteins and peptides derived from this species venom by using high resolution two-dimensional electrophoresis and MALDI ToF/ToF mass spectrometry. A total of 11 protein classes have been identified mainly proteases but also L-amino acid oxidases, C-type lectin like proteins, cysteine-rich venom proteins and phospholipases A2 and 5 peptides of molecular weight less than 1500 Da. Most of the identified proteins are responsible for the highly hemotoxic properties of the venom. Presence of venom phospholipases A2 and L- amino acid oxidases cause moderate neuro-, myo- and cytotoxicity. All successfully identified peptides belong to the bradikinin-potentiating peptides family.
2016-12-12 | PXD004958 | Pride